Dr Kneeland Youngblood - Jun 8, 2022 Form 4 Insider Report for Light & Wonder, Inc. (LNW)

Role
Director
Signature
/s/ James Sottile, attorney-in-fact for Dr. Kneeland Youngblood
Stock symbol
LNW
Transactions as of
Jun 8, 2022
Transactions value $
$0
Form type
4
Date filed
6/10/2022, 04:53 PM
Previous filing
Jan 31, 2022
Next filing
Jun 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LNW Common Stock Options Exercise $0 +2.76K +46.45% $0.00 8.71K Jun 9, 2022 Direct
transaction LNW Common Stock Options Exercise $0 +2.09K +24.03% $0.00 10.8K Jun 10, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LNW Restricted Stock Units Award $0 +3.84K $0.00 3.84K Jun 8, 2022 Common Stock 3.84K Direct F1
transaction LNW Restricted Stock Units Options Exercise $0 -2.76K -100% $0.00* 0 Jun 9, 2022 Common Stock 2.76K Direct F2
transaction LNW Restricted Stock Units Options Exercise $0 -2.09K -33.33% $0.00 4.19K Jun 10, 2022 Common Stock 2.09K Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units are scheduled to vest on June 8, 2023. Each unit converts into a share of common stock on a one-for-one basis.
F2 Represents vesting of restricted stock units granted on June 9, 2021. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis.
F3 Represents vesting of one-fourth of restricted stock units granted on June 10, 2020. The balance of the award is scheduled to vest in two equal installments on each of June 10, 2023 and June 10, 2024. Each unit converts into a share of common stock on a one-for-one basis.